Skip to main content
. 2016 Jul;16(16):1764–1791. doi: 10.2174/1568026616999160315130832

Fig. (11).

Fig. (11)

Schematic representation of the binding sites of different modulators. Left: structure of the transmembrane domain of the channel, with indication of the interaction sites of Cs+ and ivabradine. Right: structure of the HCN2 cytosolic C-terminal domain (PDB code 1Q5O) with indication on the binding sites of cyclic nucleotides and the ancillary protein TRIP8b.